Of the 15 patients who were excluded from the study, 5 patients had abnormal baseline TFTs, 4 patients were already receiving thyroid hormone replacement due to underlying thyroid disease and 6 patients received sunitinib treatment for less than 4 weeks. This evidence concerns the gene TG and thyroiditis.